RareCyte Funding: $120M Raised, Growth (2024)

RareCyte funding overview

RareCyte is based in Seattle. RareCyte has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in June 2024. The round record for RareCyte runs through 2024; nothing later has been disclosed. Investors on record include Forest Road, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, 5AM Ventures, Agilent Technologies. 6 distinct backers are named across the disclosed rounds.

RareCyte at a glance

Total raised: $120M
Latest round: Growth
Latest round date: June 2024
Headquarters: Seattle
Notable investors: Forest Road, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, 5AM Ventures, Agilent Technologies

Frequently asked about RareCyte funding

How much has RareCyte raised?: RareCyte has raised $120M in total disclosed funding across the rounds on record.
Who has invested in RareCyte?: Forest Road, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, 5AM Ventures, Agilent Technologies are named among the investors backing RareCyte.
What was the latest RareCyte funding round?: The most recent disclosed round is a Growth, announced in June 2024.
Where is RareCyte based?: RareCyte is based in Seattle.
When did RareCyte last raise?: The last disclosed RareCyte round closed in June 2024 at Growth.

We update the RareCyte record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Seattle and their backers are listed below.

RareCyte Funding: $120M Raised, Growth (2024)

RareCyte funding overview

RareCyte at a glance

Frequently asked about RareCyte funding

Companies related to RareCyte (18)

Browse related funding lists (8)